Clinical Trial Update: Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating triptorelin in combination with exemestane or tamoxifen for premenopausal women with hormone-responsive breast cancer; study com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Aromasin (exemestane)
• Nolvadex (tamoxifen)
• TRELSTAR (Triporelin pamoate)

Snippet

Sponsor: ETOP IBCSG Partners Foundation | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED | Results posted: 2016-04-05